Coulter Partners at BioCapital Europe 2025: Innovation and optimism reign

Attending the event, Justine McIlroy, Kay Wardle, Laura Esam and Philipp Buis witnessed a surge of innovation and a renewed sense of optimism.

We observed increased investor activity, with a focus on building strong investment pipelines despite the current challenging market conditions.

The event showcased an interesting line up of companies, featuring cutting-edge research and promising therapeutic approaches.

Notable, was the resurgence of neuroscience, with updates from EQT Life Sciences dedicated Dementia Fund and an insightful presentation on the history of Alzheimer's disease by the founder of BioArctic, Lars Lannfelt. The event also hosted interesting panels on Radiopharmaceuticals and ADCs.

Our team enjoyed connecting with key players in the Benelux region, fostering valuable relationships and exploring potential collaborations.

A big thank you to all who attended!